Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
10.79B | 10.54B | 10.13B | 8.56B | 6.17B | 6.11B | Gross Profit |
5.18B | 5.05B | 4.84B | 4.21B | 2.96B | 2.87B | EBIT |
834.70M | 927.20M | 931.50M | 1.02B | 385.00M | 426.60M | EBITDA |
1.42B | 1.57B | 1.20B | 1.59B | 869.20M | 878.00M | Net Income Common Stockholders |
320.70M | 538.80M | 226.70M | 369.70M | 224.30M | 246.10M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
946.30M | 1.15B | 1.58B | 1.31B | 964.40M | 465.90M | Total Assets |
9.35B | 8.05B | 8.02B | 7.07B | 5.16B | 4.35B | Total Debt |
3.78B | 2.61B | 2.45B | 2.37B | 2.10B | 2.03B | Net Debt |
2.83B | 1.46B | 869.90M | 1.06B | 1.13B | 1.56B | Total Liabilities |
6.51B | 5.18B | 5.39B | 4.73B | 3.67B | 3.06B | Stockholders Equity |
2.41B | 2.46B | 2.12B | 1.93B | 1.24B | 1.22B |
Cash Flow | Free Cash Flow | ||||
630.20M | 611.30M | 735.00M | 1.02B | 938.30M | 683.60M | Operating Cash Flow |
1.16B | 1.14B | 1.08B | 1.27B | 1.06B | 854.00M | Investing Cash Flow |
-1.33B | -543.50M | -320.90M | -848.10M | -334.70M | -261.70M | Financing Cash Flow |
-291.10M | -1.01B | -479.20M | -83.60M | -239.70M | -371.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £4.11B | 8.45 | 18.22% | 1.67% | 2.85% | 61.98% | |
76 Outperform | £2.34B | 15.50 | 84.81% | 2.80% | 3.07% | 1.42% | |
69 Neutral | £3.00B | 10.15 | 16.46% | ― | -6.82% | -37.46% | |
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
49 Neutral | £376.54M | ― | -62.59% | ― | -15.86% | -18.46% | |
49 Neutral | £364.01M | ― | -27.20% | ― | -14.37% | -28.78% | |
48 Neutral | £267.10M | ― | -96.36% | ― | -16.32% | -202.39% |